⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Pomerantz LLP Issues Important Reminder to Shareholders in MoonLake Immunotherapeutics of Class Action Filing – MLTX
accessnewswire.com
MLTX
MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX
MLTX INVESTOR REMINDER: MoonLake Immunotherapeutics Investors are Encouraged to Act in Securities Class Action - Contact BFA Law by December 15 Deadline
accessnewswire.com
MLTX
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
newsfilecorp.com
MLTX
Class Action Lawsuit Filed Against MoonLake Immunotherapeutics (MLTX) - Recover Losses - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors are Reminded to Contact BFA Law before the Imminent December 15 Securities Class Action Deadline
newsfilecorp.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX
globenewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Issues Important Reminder to Shareholders in MoonLake Immunotherapeutics of Class Action – MLTX
accessnewswire.com
MLTX
MLTX Deadline: MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX